Greenway Greenhouse CannabisGWAYF +0.94%24 PB Ratio is 1.89 as of Jun. 30, 2026, which is 32% below its 10-year median of 2.79. GuruFocus rates GWAYF with a GF Score™ of 24/100 and a GF Value™ of $0.28 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 920 Drug Manufacturers companies, Greenway Greenhouse Cannabis ranks worse than 53.8% on this metric.
Greenway Greenhouse Cannabis Corp stock PB Ratio (=2.03) is close to 2-year low of 1.87.
The historical rank and industry rank for Greenway Greenhouse Cannabis's PB Ratio or its related term are showing as below:
GWAYF'
s PB Ratio Range Over the Past 10 Years
Min: 1.39 Med: 2.79 Max: 15.35
Current: 2.04
During the past 5 years, Greenway Greenhouse Cannabis's highest PB Ratio was 15.35. The lowest was 1.39. And the median was 2.79.
GWAYF's PB Ratio is ranked worse than 53.8% of 920
companies
in the Drug Manufacturers industry
Industry Median: 1.845
vs GWAYF: 2.04
During the past 3 years, the average Book Value Per Share Growth Rate was -16.20% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Greenway Greenhouse Cannabis was 2.70% per year. The lowest was -16.20% per year. And the median was -6.75% per year.
Back to Basics: PB Ratio
Greenway Greenhouse Cannabis (OTCPK:GWAYF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Greenway Greenhouse Cannabis PB Ratio Related Terms
Greenway Greenhouse Cannabis PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Greenway Greenhouse Cannabis's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Greenway Greenhouse Cannabis PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Greenway Greenhouse Cannabis's PB Ratio distribution charts can be found below:
* The bar in red indicates where Greenway Greenhouse Cannabis's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Greenway Greenhouse Cannabis (GWAYF) has a PB Ratio of 1.89 as of Jun. 30, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Greenway Greenhouse Cannabis and its competitors. This is 32% below median its historical median of 2.79. Over the past decade, Greenway Greenhouse Cannabis' PB Ratio has ranged from 1.39 to 15.35. According to the industry distribution chart, Greenway Greenhouse Cannabis ranks #495 out of 920 companies in the Drug Manufacturers industry, placing it in the top 53.8%.
Is Greenway Greenhouse Cannabis' PB Ratio too high?
Greenway Greenhouse Cannabis' current PB Ratio of 1.89 is 32% below median its 10-year median of 2.79. Over the past 10 years, this metric has ranged from a low of 1.39 to a high of 15.35. The Drug Manufacturers industry median PB Ratio is 1.85. Greenway Greenhouse Cannabis' value of 1.89 is 2.4% above this industry median. Based on the distribution chart, Greenway Greenhouse Cannabis ranks #495 out of 920 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Greenway Greenhouse Cannabis has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Greenway Greenhouse Cannabis' PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Greenway Greenhouse Cannabis ranks #495 out of 920 companies for PB Ratio. This places Greenway Greenhouse Cannabis in the lower half of its industry. The industry median PB Ratio is 1.85. Greenway Greenhouse Cannabis' value of 1.89 is 2.4% above this benchmark. Historically, Greenway Greenhouse Cannabis' own PB Ratio has ranged from 1.39 to 15.35 over the past decade. While the company's 10-year median is 2.79 vs. the industry median of 1.85, Greenway Greenhouse Cannabis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.85, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Greenway Greenhouse Cannabis's current PB Ratio of 1.89 is 2.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Greenway Greenhouse Cannabis and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Greenway Greenhouse Cannabis's current PB Ratio is 1.89, which is 32% below median its own 10-year median of 2.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenway Greenhouse Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Greenway Greenhouse Cannabis (GWAYF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.28, compared to a current price of $0.10 — trading 63.6% below its estimated fair value. The current PB Ratio is 1.89, which is 32% below median its 10-year median of 2.79 and 2.4% above the Drug Manufacturers industry median of 1.85. Greenway Greenhouse Cannabis' overall GF Score™ is 24/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Greenway Greenhouse Cannabis (GWAYF), the current PB Ratio is 1.89 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Greenway Greenhouse Cannabis (GWAYF) Overvalued in 2026?
Based on GuruFocus' analysis, Greenway Greenhouse Cannabis stock appears to be undervalued.
The current stock price of $0.10 is trading 63.6% below its estimated GF Value™ of $0.28.
GuruFocus considers Greenway Greenhouse Cannabis to be Possible Value Trap.
Key valuation signals for GWAYF:
PB Ratio: 1.89 (32% below median its 10-year median of 2.79)
GF Value™: $0.28 vs. price of $0.10 (63.6% below fair value)
Industry Position: 2.4% above the Drug Manufacturers median (#495 of 920)
No single metric tells the full story. See the GWAYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Greenway Greenhouse Cannabis Corp is licensed to cultivate, process and sell to ensures harvests always consist of the highest quality cannabis strains with resinous flowers, trichomes, and rich cannabinoid profiles. The Company's nursery facility is located in Kingsville, Ontario, and its flowering and processing facility is located in Leamington, Ontario. The business model is to supply bulk packaged, high quality cannabis to the Canadian, cannabis industry at prices that ultimately provide a value proposition to the consumers. Greenway has three divisions with various locations; Greenway Nursery, Greenway Cultivation and future plans for Greenway Farmgate Retail Store.
24GF Score
Get the complete analysis for GWAYF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GWAYF has been successfully added to your 
